Letters Section Editor: Robert M. Golub,
MD, Senior Editor.
To the Editor: The results of the study by
Dr D’Amico and colleagues1 regarding
the survival benefit of combining androgen suppression therapy and radiation
therapy for treatment of localized prostate cancer seem to include a discrepancy.
The text notes 6 deaths due to prostate cancer in the 3-dimensional conformal
radiation therapy group; however, the graph and related data in Figure 3 appear
to indicate only 4 prostate cancer deaths.
Millar J. Androgen Suppression Plus Radiation for Prostate Cancer. JAMA. 2004;292(21):2581-2582. doi:10.1001/jama.292.21.2581-b